Assessment of The Broad-Spectrum Host Targeting Antiviral Efficacy of Halofuginone Hydrobromide in Human Airway, Intestinal and Brain Organoid Models.
I. Garcia-Rodriguez, G. Moreni, P. E. Capendale, I. Aknouch, L. A. Mulder, N. Johannesson, R. Vieira de Sa, E. Freeze, H. van Eijk, G. Koen, K. C. Wolthers, D. Pajkrt, A. Sridhar, C. Calitz
This study evaluates the antiviral efficacy of halofuginone hydrobromide against multiple viruses in human organoid models, finding it effective only against SARS-CoV-2.
bioRxiv · Nov 1, 2023 · PreprintMicrobiology